Sfoglia per AUTORE
MILANO G
Collezione AO Cuneo
Items : 5
Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation. in Cancer treatment reviews / Cancer Treat Rev. 2018 Feb;63:48-60. doi: 10.1016/j.ctrv.2017.11.008. Epub 2017 Dec 2.
2018
AO Cuneo
AO Cuneo
Merlano M; Audhuy F; Schulten J; García-Foncillas J; Trotta AM; Lenz HJ; Ferris RL; Milano G;
Schedule-dependent interaction between temsirolimus and cetuximab in head and neck cancer: a preclinical study. in Anti-cancer drugs / Anticancer Drugs. 2016 Jul;27(6):533-9. doi: 10.1097/CAD.0000000000000360.
2016
AO Cuneo
AO Cuneo
Lattanzio L; Milano G; Monteverde M; Tonissi F; Vivenza D; Merlano M; Lo Nigro C;
The relevance of ADCC for EGFR targeting: A review of the literature and a clinically-applicable method of assessment in patients. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2015 Aug;95(2):179-90. doi: 10.1016/j.critrevonc.2015.02.014. Epub 2015 Mar
2015
AO Cuneo
AO Cuneo
Monteverde M; Milano G; Strola G; Maffi M; Lattanzio L; Vivenza D; Tonissi F; Merlano M; Lo Nigro C;
Impact of erythropoietin on the effects of irradiation under hypoxia. in Journal of cancer research and clinical oncology / J Cancer Res Clin Oncol. 2009 Nov;135(11):1615-23. doi: 10.1007/s00432-009-0609-1. Epub 2009 Jun 5.
2009
AO Cuneo
AO Cuneo
Lo Nigro C; Maffi M; Fischel JL; Monteverde M; Catarsi P; Tonissi F; Lattanzio L; Riba M; Etienne-Grimaldi MC; Formento P; Milano G; Merlano M;
The combination of docetaxel and the somatostatin analogue lanreotide on androgen-independent docetaxel-resistant prostate cancer: experimental data. in BJU international / BJU Int. 2008 Aug 5;102(5):622-7. doi: 10.1111/j.1464-410X.2008.07706.x. Epub 2008 May 20.
2008
AO Cuneo
AO Cuneo
Lo Nigro C; Maffi M; Fischel JL; Formento P; Milano G; Merlano M;